CMS Open Payments · Program Year 2024
Levita Magnetics International Corp.
Levita Magnetics International Corp. reported $2,426.15 across General Payments, Research, and Ownership to 60 physicians and teaching hospitals across 60 transactions.
- $2.4K Below-median payer
- All-tracks total
- 60 Below-median volume
- Transactions
- 60 Below-median reach
- Recipients
- −$2.0K
- General Payments vs PY2023
Levita Magnetics International Corp. reported $2,426.15 across all CMS Open Payments tracks (General + Research + Ownership) to 60 physicians and teaching hospitals in Program Year 2024 - ranking #1783 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,426.15, averaging $40.44 per recipient.
Levita Magnetics International Corp.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer levita-magnetics-international-corp Levita Magnetics International Corp.
$2.4K · #1783/1,925 · 0.0% industry · PY2024
- TOT $2.4K
- RANK #1783
- SHARE 0.0%
- TXN 60
- RCP 60
- CAT 3
- GEN $2.4K
- ΔGEN −$2.0K
- TOP1 52.0%
- PY 2024
Volume peers
Nearest volume peer: Elekta Solutions AB ($2.4K)
Levita Magnetics International Corp. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Levita Magnetics International Corp.'s CMS-reported General Payments decreased by $2.0K (−45.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: LEVITA MAGNETICS INTERNATIONAL CORP.PY2024: Levita Magnetics International Corp.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,444.01
- PY2024
- $2,426.15
What the Data Shows for Levita Magnetics International Corp.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Levita Magnetics International Corp. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Food and Beverage" leads the 3-category general-payment breakdown below at $1.2K (48.5% of General Payments, 58 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 3 types of general payments, Levita Magnetics International Corp.'s largest category was "Food and Beverage" at $1.2K - 48.5% of General Payments.
How Levita Magnetics International Corp. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $1.2K | 58 | 48.5% |
| Consulting Fee | $1.0K | 1 | 41.2% |
| Compensation for Faculty or Speaker (Medical Education) | $250.00 | 1 | 10.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,050.91 (84.5%) of $2,426.15 in this company's General Payments records across 24 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Levita Magnetics International Corp.
The five named recipients with the highest reported General Payments from this company
- 1
Matthew Kroh
$1,262.79 across 3 reported transactions
- 2
Chad Joseph Carlton
$478.41 across 22 reported transactions
- 3
Kristy Dalynn Carlton
$121.26 across 4 reported transactions
- 4
Mohammad Azam Farukhi
$116.26 across 1 reported transactions
- 5
Preethi George
$72.19 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Levita Magnetics International Corp. ranks #1783 of 1,925 by total payments (bottom 7% by spend) but is notably more concentrated than that alone would suggest -- #549 of 1,838 by HHI (top 30% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Carbofix Spine Inc : $52.0K total payments, HHI 3217
- ICU Medical Inc : $55.8K total payments, HHI 3209
- Emergent BioSolutions Inc. : $6.8K total payments, HHI 3205
- Atlas Ocular, Inc : $35.4K total payments, HHI 3194
- HF Acquisition Co. LLC : $46.1K total payments, HHI 3193
- Okami Medical, Inc. : $92.0K total payments, HHI 3180
- Levita Magnetics International Corp. (this company) : $2.4K total payments, HHI 3174
- Perspectum Diagnostics Ltd : $1.1M total payments, HHI 3165
- Veru Inc. : $149.5K total payments, HHI 3151
- Merete Technologies, Inc : $72.1K total payments, HHI 3135
- Vifor (International) Ltd. : $132.0K total payments, HHI 3112
- Asklepios Biopharmaceutical Inc. : $7.6M total payments, HHI 3111
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Levita Magnetics International Corp.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Levita Magnetics International Corp..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Levita Magnetics International Corp..
Showing 6 of 1,924 companies with CMS-reported payment data.
CPM Medical Consultants, LLC
Ortho Systems
Surgebright Inc.
IsoRay, Inc
Oxford Gene Technology Inc
Put this to use
Levita Magnetics International Corp. ranks #1783 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Levita Magnetics International Corp.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.